Stress-induced cigarette craving: effects of the DRD2 TaqI RFLP and SLC6A3 VNTR polymorphisms (original) (raw)
World Health Organization. Tobacco or Health: A Global Status Report. 1997.
Zhu S, Melcer T, Sun J, Rosbrook B, Pierce J . Smoking cessation with and without assistance: a population analysis. Am J Prev Med 2000; 18: 305–311. ArticleCASPubMed Google Scholar
Heath A, Martin N . Genetic models for the natural history of smoking: evidence for a genetic influence on smoking persistence. Addict Behav 1993; 18: 19–34. ArticleCASPubMed Google Scholar
Blum K, Noble E, Sheridan P, Montgomery A, Ritchie T, Jagadeeswaran P et al. Allelic association of human D2 dopamine receptor gene in alcoholism. JAMA 1990; 263: 2055–2060. ArticleCASPubMed Google Scholar
Noble E . The D2 dopamine receptor gene: a review of association studies in alcoholisms and phenotypes. Alcohol 1998; 16: 33–45. ArticleCASPubMed Google Scholar
Persico A, Bird G, Gabbay F, Uhl G . D2 dopamine receptor gene _Taq_I A1 and B1 restriction fragment length polymorphisms: enhanced frequencies in psychostimulant-preferring polysubstance abusers. Biol Psychiatry 1996; 40: 776–784. ArticleCASPubMed Google Scholar
Comings D, Ferry L, Bradshaw-Robinson S, Burchette R, Chiu C, Muhleman D . The dopamine D2 receptor (DRD2) gene: a genetic risk factor in smoking. Pharmacogenetics 1996; 6: 73–79. ArticleCASPubMed Google Scholar
Bierut L, Rice J, Edenberg H, Goate A, Foroud T, Cloninger C et al. Family-based study of the association of the dopamine D2 receptor gene (DRD2) with habitual smoking. Am J Med Genet 2000; 90: 299–302. ArticleCASPubMed Google Scholar
Spitz M, Shi H, Yang F, Hudmon K, Jiang H, Chamberlain R et al. Case–control study of the D2 dopamine receptor gene and smoking status in lung cancer patients. J Natl Cancer Inst 1998; 90: 358–363. ArticleCASPubMed Google Scholar
Noble E . D2 dopamine receptor gene in psychiatric and neurologic disorders and its phenotypes. Am J Med Genet, Part B 2003; 116B: 103–125. Article Google Scholar
Gelernter J, O'Malley S, Risch N, Kranzler H, Krystal J, Merikangas K et al. No association between an allele at the D2 dopamine receptor gene (DRD2) and alcoholism. JAMA 1991; 266: 1801–1807. ArticleCASPubMed Google Scholar
Edenberg H, Foroud T, Koller D, Goate A, Rice J, Van Eerdewegh P et al. A family-based analysis of the association of the dopamine D2 receptor (DRD2) with alcoholism. Alcohol Clin Exp Res 1998; 22: 505–512. ArticleCASPubMed Google Scholar
Lee H . Gender-specific molecular heterosis and association studies: dopamine D2 receptor gene and smoking. Am J Med Genet, Part B 2003; 118B: 55–59. Article Google Scholar
Limosin F, Gorwood P, Loze J, Dubertret C, Gouya L, Deybach J et al. Male limited association of the dopamine receptor D2 gene _Taq_I A polymorphism and alcohol dependence. Am J Med Genet 2003; 112: 343–346. Article Google Scholar
Self D . Neural substrates of drug craving and relapse in drug addiction. Ann Med 1998; 30: 379–389. ArticleCASPubMed Google Scholar
Sander T, Harms H, Podschus J, Finckh U, Nickel B, Rolfs A et al. Allelic association of a dopamine transporter gene polymorphism in alcohol dependence with withdrawal seizures or delirium. Biol Psychiatry 1997; 41: 299–304. ArticleCASPubMed Google Scholar
Schmidt L, Harms H, Kuhn S, Rommelspacher H, Sander T . Modification of alcohol withdrawal by the A9 allele of the dopamine transporter gene. Am J Psychiatry 1998; 155: 474–478. ArticleCASPubMed Google Scholar
Lerman C, Caporaso N, Audrain J, Main D, Bowman E, Lockshin B et al. Evidence suggesting the role of specific genetic factors in cigarette smoking. Health Psychol 1999; 18: 14–20. ArticleCASPubMed Google Scholar
Jorm A, Henderson A, Jacomb P, Christensen H, Korten A, Rodgers B et al. Association of smoking and personality with a polymorphism of the dopamine transporter gene. Am J Med Genet 2000; 96: 331–334. ArticleCASPubMed Google Scholar
Vandenbergh D, Bennet C, Grant M, Strasser A, O'Connor R, Stauffer R et al. Smoking status and the human dopamine transporter variable number of tandem repeats (VNTR) polymorphism: failure to replicate and finding that never smokers may be different. Nicotine Tob Res 2002; 4: 333–340. ArticlePubMed Google Scholar
Martinez D, Gelernter J, Abi-Dargham A, van Dyck C, Kegeles L, Innis R et al. The variable number of tandem repeats polymorphism of the dopamine transporter gene is not associated with significant change in dopamine transporter phenotype in humans. Neuropsychopharmacology 2001; 24: 553–560. ArticleCASPubMed Google Scholar
Michelaugh S, Fiskerstrand C, Lovejoy E, Bannon M, Quinn J . The dopamine transporter gene (SLC6A3) variable number of tandem repeats domain enhances transcription in dopamine neurons. J Neurochem 2001; 79: 1033–1038. Article Google Scholar
Lerman C, Swan G . Non-replication of genetic association studies: is DAT all folks? Nicotine Tob Res 2002; 4: 247–249. ArticlePubMed Google Scholar
Shaham Y, Stewart J . Stress reinstates heroin-seeking in drug-free animals: an effect mimicking heroin, not withdrawal. Psychopharmacology 1995; 119: 334–341. ArticleCASPubMed Google Scholar
Shaham Y, Stewart J . Effects of opioid and dopamine receptor antagonists on relapse induced by stress and re-exposure to heroin in rats. Psychopharmacology 1995; 125: 385–391. Article Google Scholar
Buczek Y, Le A, Wang A, Stewart J, Shaham Y . Stress reinstates nicotine seeking but not sucrose solution seeking in rats. Psychopharmacology 1999; 144: 183–188. CASPubMed Google Scholar
Sinha R . How does stress increase risk of drug abuse and relapse? Psychopharmacology 2001; 158: 343–359. ArticleCASPubMed Google Scholar
Drobes D, Tiffany S . Induction of smoking urge through imaginal and in vivo procedures: physiological and self-report manifestations. J Abnormal Psychol 1997; 106: 15–25. ArticleCAS Google Scholar
Childress A, Ehrman R, McLellan A, MacRae J, Natale M, O'Brien C . Can induced moods trigger drug-related responses in opiate abuse patients? J Subst Abuse Treat 1994; 11: 17–23. ArticleCASPubMed Google Scholar
Heatherton T, Kozlowski L, Frecker T, Fagerstrom K . The Fagerström test for nicotine dependence: a revision of the Fagerström tolerance questionnaire. Br J Addict 1991; 86: 1119–1127. ArticleCASPubMed Google Scholar
Hughes J, Hatsukami D . Signs and symptoms of tobacco withdrawal. Arch Gen Psychiatry 1986; 43: 289–294. ArticleCASPubMed Google Scholar
Kozlowski L, Wilkinson D, Phil D . Use and misuse of the concept of craving by alcohol, tobacco, and drug researchers. Br J Addict 1987; 82: 31–36. ArticleCASPubMed Google Scholar
Hutchison K, Niaura R, Swift R . Smoking cues decrease prepulse inhibition of the startle response and increase subjective craving in humans. Exp Clin Psychopharm 1999; 7: 250–256. ArticleCAS Google Scholar
Bond A, Lader M . The use of analogue scales in rating subjective feelings. Br J Med Psychol 1974; 47: 211–218. Article Google Scholar
Gelernter J, Kranzler H, Lacobelle J . Population studies of polymorphisms at loci of neuropsychiatric interest (tryptophan hydroxylase (TPH), dopamine transporter protein (SLC6A3), D3 dopamine receptor (DRD3), apolipoprotein E (APOE), mu opioid receptor (OPRM1), and ciliary neurotrophic factor (CNTF)). Genomics 1998; 52: 289–297. ArticleCASPubMed Google Scholar
Grandy DK, Zhang Y, Civelli O . PCR detection of the TaqA RFLP at the DRD2 locus. Hum Mol Genet 1993; 2: 2197. ArticleCASPubMed Google Scholar
Tucker L, Damarin F, Messick S . A base-free measure of change. Psychometrika 1966; 31: 457–473. ArticleCASPubMed Google Scholar
Pedhazur E Multiple Regression in Behavioral Research, 3rd edn. Harcourt Brace: Fort Worth, TX 1997. Google Scholar
Swan G . Multiple risk factors for the initiation of smoking: the public health imperative for multidisciplinary genetic epidemiological investigations of nicotine addiction. Nicotine Tob Res 1999; 1(Suppl 2): S71–S73. ArticlePubMed Google Scholar
Gelernter J, Kranzler H, Cubells J, Ichinose H, Nagatsu T . DRD2 allele frequencies and linkage disequilibria, including the −141CIns/Del promoter polymorphism, in European-American, African-American, and Japanese subjects. Genomics 1998; 51: 21–26. ArticleCASPubMed Google Scholar
Lawford B, Young R, Rowell J, Qualichefski J, Fletcher B, Syndulko K, Ritchie T et al. Bromocriptine in the treatment of alcoholics with the D2 dopamine receptor A1 allele. Nat Med 1995; 1: 337–341. ArticleCASPubMed Google Scholar
Caskey N, Jarvik M, Wirshing W . The effects of dopaminergic D2 stimulation and blockade on smoking behavior. Exp Clin Psychopharmacol 1999; 7: 72–78. ArticleCASPubMed Google Scholar
Caskey N, Jarvik M, Wirshing W, Madsen D, Iwamoto-Schaap P, Eisenberger N et al. Modulating tobacco smoking rates by dopaminergic stimulation and blockade. Nicotine Tob Res 2002; 4: 259–266. ArticleCASPubMed Google Scholar